LAS VEGAS, Mar 30, 2004 (BUSINESS WIRE) -- Nutri Pharmaceuticals Research Inc. (Pink Sheets: NRIP) announced the filing of the first of a series of patent applications for the protection of its O2P(TM) (Oil-to-Powder) processes. The company has a variety of proprietary processes for different O2P(TM) applications and regulatory "label" requirements.
"Intellectual property protection for our processes and products is important for our continued growth," said Godfrey Yew, president and CEO.
The increased sales of the company's proprietary Oil-to-Powder (O2P) product line is the single greatest factor in the record sales of the first quarter.
The company's proprietary O2P(TM) process transforms most edible oils into a free-flowing powder form without the application of heat, thus delivering more of the natural active components than competing processes. Such powdered oils have application and demand in the food ingredient, livestock feeds, pet foods, nutraceutical, cosmetic, and pesticide market sectors.
The company also continues to manufacture vitamins and health food supplements for the wholesale "private label" market.
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements can be identified by the lead-in "Looking Forward." These statements are not guarantees of future performance and involve significant risks and uncertainties. Actual results may vary materially from those in the forward-looking statements as a result of the effectiveness of management's strategies and decisions, general economic and business conditions, new or modified statutory or regulatory requirements, and changing price and market conditions. No assurance can be given that these are all the factors that could cause actual results to vary materially from the forward-looking statement.